2nd World Conference on Breast Cancer and Cancer Research

Track: Cancer Subtypes

Prostate Cancer

This session will delve into the latest developments in prostate cancer research and treatment, focusing on novel therapeutic approaches, advancements in diagnostics, and strategies for managing the disease. Attendees will gain insights into current research trends, innovative treatments, and the future directions of prostate cancer care.

Lung Cancer

In lung cancer, liquid biopsies and immunotherapy are revolutionizing treatment approaches. Recent studies emphasize the importance of tumor mutational burden and PD-L1 expression for predicting responses to checkpoint inhibitors. Staying updated on these innovations is essential for researchers and clinicians aiming to enhance patient care and therapeutic efficacy.

Colorectal Cancer

Colorectal cancer research has uncovered the significant role of the microbiome in tumor development and treatment response. Advances in identifying genetic mutations and epigenetic markers are paving the way for targeted therapies and improved early detection methods, offering avenues for research and clinical application.

Stomach (Gastric) Cancer

Molecular classification of stomach cancer is guiding targeted therapies like HER2 inhibitors for specific tumor subtypes. Recent research is exploring the impact of these advancements on patient prognosis and treatment personalization, providing valuable insights for researchers and healthcare providers involved in managing gastric cancer.

Pancreatic Cancer

Research into pancreatic cancer is focusing on overcoming challenges related to its aggressive nature. Innovations include exploring the tumor microenvironment and novel drug delivery systems, aiming to enhance therapeutic efficacy and improve patient outcomes. These developments are critical for researchers tackling this difficult cancer.

Liver Cancer

Recent studies on liver cancer have identified key signaling pathways involved in hepatocellular carcinoma, leading to recent targeted and immunotherapies. Insights into the molecular mechanisms of liver carcinogenesis are informing clinical trials and improving treatment strategies, essential for researchers and clinicians in the field.

Thyroid Cancer

Thyroid cancer research is advancing with latest discoveries in genetic mutations and epigenetic alterations. These findings are enhancing accuracy and enabling the development of personalized treatment regimens, offering researchers and clinicians updated tools for managing various thyroid cancer subtypes.

Kidney (Renal) Cancer

Recent advancements in kidney cancer research emphasize the importance of genomic profiling and the tumor immune microenvironment. Recently targeted therapies and immune checkpoint inhibitors are being developed to improve outcomes, providing researchers and clinicians with innovative strategies to tackle renal cancer.

Brain Cancer

Brain cancer research is making strides with insights into the molecular and genetic characteristics of tumors. Advances in imaging and genomics are facilitating the development of personalized treatments and novel therapeutics, crucial for researchers and healthcare providers focused on brain cancer management.

Uterine Cancer

In uterine cancer research, recent studies focus on molecular subtypes and their impact on treatment responses. Emerging biomarkers are guiding therapy decisions, offering researchers and clinicians valuable tools to tailor treatments and improve outcomes for patients with uterine cancer.

Oral and Oropharyngeal Cancer

Research in oral and oropharyngeal cancers is uncovering the role of HPV in disease progression. Advances in genomic and molecular profiling are guiding the development of targeted therapies and personalized treatment strategies, essential for researchers and clinicians working in this field.

Skin Cancer

Skin cancer research, particularly melanoma, is advancing with latest insights into resistance mechanisms to immunotherapy. Combining treatments and exploring novel therapeutic options are critical for improving patient outcomes, and providing researchers and clinicians with up-to-date strategies for effective skin cancer management.

Ovarian Cancer

Recent studies in ovarian cancer are revealing genetic mutations and molecular pathways involved in disease progression. Targeted therapies and innovative treatment strategies are emerging, offering researchers and clinicians enhanced tools to address ovarian cancer and improve patient care.

Esophageal Cancer

Research on esophageal cancer is uncovering novel biomarkers and advancing targeted therapies. These developments are crucial for improving patient outcomes and providing researchers and clinicians with recent treatment options, reflecting the latest progress in managing this challenging cancer.

2nd World Conference on Breast Cancer and Cancer Research

Track: Cancer Subtypes

Scientific Highlights

Organization Location

Mail us at

Our Social Presence

Call us at